These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control]. Shionoiri H; Yasuda G; Takizawa T; Shionoiri F Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741 [No Abstract] [Full Text] [Related]
6. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
7. The end of the road for dual renin-angiotensin system blockade in diabetic nephropathy: which way now? Advani A Can J Diabetes; 2014 Oct; 38(5):292-5. PubMed ID: 25172268 [No Abstract] [Full Text] [Related]
8. ACE inhibitors and diabetics with albuminuria. The DIABHYCAR Study Group. Marre M; Lievre M; Chatellier G; Plouin PF Lancet; 1995 Dec; 346(8990):1638. PubMed ID: 7500787 [No Abstract] [Full Text] [Related]
9. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. Cooper ME J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709 [TBL] [Abstract][Full Text] [Related]
10. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Jacobsen P; Andersen S; Rossing K; Jensen BR; Parving HH Kidney Int; 2003 May; 63(5):1874-80. PubMed ID: 12675866 [TBL] [Abstract][Full Text] [Related]
12. Enalapril treatment increases T cell number and promotes polarization towards M1-like macrophages locally in diabetic nephropathy. Cucak H; Nielsen Fink L; Højgaard Pedersen M; Rosendahl A Int Immunopharmacol; 2015 Mar; 25(1):30-42. PubMed ID: 25598292 [TBL] [Abstract][Full Text] [Related]
13. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P; Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383 [TBL] [Abstract][Full Text] [Related]
14. Clinical Inquiry: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP? Trietley GS; Wilson SA; Chaudhri P; Payette N; Higbea A; Nashelsky J J Fam Pract; 2017 Apr; 66(4):257-263. PubMed ID: 28375400 [TBL] [Abstract][Full Text] [Related]
15. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy. Pathak JV; Dass EE Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372 [TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment. Barri YM; Palmer BF; Ram CV Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709 [TBL] [Abstract][Full Text] [Related]
18. Reviewing the benefits of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy--are they drug specific or class specific? Burgess E Can J Cardiol; 2010 Dec; 26 Suppl E():15E-19E. PubMed ID: 21620286 [TBL] [Abstract][Full Text] [Related]
19. [ACE inhibitors and early diabetic nephropathy]. Bangstad HJ; Hartmann A; Berg TJ; Hanssen KF Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3039-41. PubMed ID: 7570536 [TBL] [Abstract][Full Text] [Related]
20. [ACE inhibitors' effect on kidney function]. Grönhagen-Riska C Nord Med; 1990; 105(8-9):219-22. PubMed ID: 2216687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]